Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications
Impact of immune-related and non-immune related hospital admissions on survival of patients with non-small cell lung cancer receiving first-line immunotherapy.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 07, 2025
Investigating risk factors and treatment options for severe, partially steroid responsive, and steroid-refractory checkpoint inhibitor pneumonitis.
Journal: The oncologist
Published: December 06, 2023
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.
Journal: Gastrointestinal endoscopy
Published: October 10, 2023
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis.
Journal: Science translational medicine
Published: June 14, 2023
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
Journal: Journal for immunotherapy of cancer
Published: June 07, 2023
Clinical Features and Management of Acute and Chronic Radiation-Induced Colitis and Proctopathy.
Journal: Cancers
Published: April 24, 2023
Maximizing the value of phase III trials in immuno-oncology: A checklist from the Society for Immunotherapy of Cancer (SITC).
Journal: Journal for immunotherapy of cancer
Published: August 20, 2022
Endoscopy for the diagnosis and treatment of gastrointestinal bleeding caused by malignancy.
Journal: Journal of gastroenterology and hepatology
Published: January 02, 2022
Outcomes of Immune Checkpoint Inhibitor-related Diarrhea or Colitis in Cancer Patients With Superimposed Gastrointestinal Infections.
Journal: American journal of clinical oncology
Published: June 09, 2021
Clinical Characteristics and Outcomes of Eosinophilic Colitis in Patients With Cancer.
Journal: American journal of clinical oncology
Published: June 06, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events.
Journal: Journal for immunotherapy of cancer
Published: March 24, 2021
Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity.
Journal: Cancer cell
Published: March 17, 2021
Last Updated: 09/26/2026